Cargando…
Quantitative Proteomic (iTRAQ) Analysis of 1st Trimester Maternal Plasma Samples in Pregnancies at Risk for Preeclampsia
A current major obstacle is that no reliable screening markers exist to detect pregnancies at risk for preeclampsia. Quantitative proteomic analysis employing isobaric labelling (iTRAQ) has been suggested to be suitable for the detection of potential plasma biomarkers, a feature we recently verified...
Autores principales: | Kolla, Varaprasad, Jenö, Paul, Moes, Suzette, Lapaire, Olav, Hoesli, Irene, Hahn, Sinuhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335425/ https://www.ncbi.nlm.nih.gov/pubmed/22570525 http://dx.doi.org/10.1155/2012/305964 |
Ejemplares similares
-
Quantitative Proteomics Analysis of Maternal Plasma in Down Syndrome Pregnancies Using Isobaric Tagging Reagent (iTRAQ)
por: Kolla, Varaprasad, et al.
Publicado: (2010) -
Determination of fetal chromosome aberrations from fetal DNA in maternal
blood: has the challenge finally been met?
por: Hahn, Sinuhe, et al.
Publicado: (2011) -
Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?
por: Hahn, Sinuhe, et al.
Publicado: (2015) -
Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum
por: Hahn, Sinuhe, et al.
Publicado: (2019) -
Excessive Neutrophil Activity in Gestational Diabetes Mellitus: Could It Contribute to the Development of Preeclampsia?
por: Vokalova, Lenka, et al.
Publicado: (2018)